Question 1

What is the catalog number for TJ08?

Accepted Answer

The catalog number for TJ08 is M36545.

Question 2

What sizes are available for TJ08?

Accepted Answer

TJ08 is available in the following size(s): 1 g, 500 mg, 100 mg, 200 mg, 5 mg, 10 mg, 25 mg.

Question 3

How many pack sizes does TJ08 come in?

Accepted Answer

TJ08 is available in 7 different pack sizes.

Question 4

Is TJ08 in stock?

Accepted Answer

TJ08 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is TJ08 used for?

Accepted Answer

TJ08 is a 1,2,5-trisubstituted benzimidazole derivative with anticancer properties that effectively induces G1/S phase blockade while promoting apoptotic effects in a variety of cancer cells.

Question 6

What dilution range is recommended for immunohistochemistry (IHC) with this antibody?

Accepted Answer

A starting IHC dilution range is listed on the datasheet, but should be optimized for your specific tissue type and staining protocol.

Question 7

Can I request a Safety Data Sheet (SDS) for this product?

Accepted Answer

Yes, safety data sheets are available for hazardous or chemically classified products and can be provided on request or downloaded from the product page.

Question 8

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

TJ08

Product Specifications

CAS Number

Stability

Purity

Weight

Molecular Formula

Notes

Receptor

Available Sizes

Frequently Asked Questions

Explore Other Products

Anti-COUTFII/NR2F2 (Rabbit, Monoclonal)

4-tert-Butylphenyl Salicylate

Anti-PDGFC / VEGFE

HRAS Rabbit pAb, Pacific Blue conjugated

mmu-miR-99a-5p miRNA Antagomir

mmu-miR-99a-5p miRNA Antagomir